Graft-versus-Host Disease: State of the Science

Amin M. Alousi; Javier Bolaños-Meade; Stephanie J. Lee

doi:10.1016/j.bbmt.2012.10.028

Graft-versus-Host Disease: State of the Science

Amin M. Alousi, Javier Bolaños-Meade, Stephanie J. Lee

School of Medicine

Research output: Contribution to journal › Article › peer-review

14 Scopus citations

Original language	English (US)
Pages (from-to)	S102-S108
Journal	Biology of Blood and Marrow Transplantation
Volume	19
Issue number	1 SUPPL.
DOIs	https://doi.org/10.1016/j.bbmt.2012.10.028
State	Published - Jan 2013

ASJC Scopus subject areas

Hematology
Transplantation

Access to Document

10.1016/j.bbmt.2012.10.028

Cite this

@article{259b195051a145bb86e2ed8b07662c08,

title = "Graft-versus-Host Disease: State of the Science",

author = "Alousi, {Amin M.} and Javier Bola{\~n}os-Meade and Lee, {Stephanie J.}",

note = "Funding Information: Chronic GVHD affects 30%-50% of allogeneic hematopoietic cell transplantation (HCT) survivors and is a major cause of morbidity and mortality. In 2004, Pavletic and Vogelsang, with support from the National Cancer Institute, Office of Rare Diseases Research, Department of Defense, National Heart, Lung and Blood Institute, Health Resources and Services Administration, and the National Institute of Allergy and Infectious Diseases, convened a Consensus Conference with the goal of advancing research in chronic GVHD. Participants in this Consensus Conference wrote 6 papers to provide the recommendations for diagnosis and scoring [23] , pathology [24] , biomarkers [25] , response criteria [26] , supportive care [27] , and design of clinical trials [28] . ",

year = "2013",

month = jan,

doi = "10.1016/j.bbmt.2012.10.028",

language = "English (US)",

volume = "19",

pages = "S102--S108",

journal = "Biology of Blood and Marrow Transplantation",

issn = "1083-8791",

publisher = "Elsevier Inc.",

number = "1 SUPPL.",

}

TY - JOUR

T1 - Graft-versus-Host Disease

T2 - State of the Science

AU - Alousi, Amin M.

AU - Bolaños-Meade, Javier

AU - Lee, Stephanie J.

N1 - Funding Information: Chronic GVHD affects 30%-50% of allogeneic hematopoietic cell transplantation (HCT) survivors and is a major cause of morbidity and mortality. In 2004, Pavletic and Vogelsang, with support from the National Cancer Institute, Office of Rare Diseases Research, Department of Defense, National Heart, Lung and Blood Institute, Health Resources and Services Administration, and the National Institute of Allergy and Infectious Diseases, convened a Consensus Conference with the goal of advancing research in chronic GVHD. Participants in this Consensus Conference wrote 6 papers to provide the recommendations for diagnosis and scoring [23] , pathology [24] , biomarkers [25] , response criteria [26] , supportive care [27] , and design of clinical trials [28] .

PY - 2013/1

Y1 - 2013/1

UR - http://www.scopus.com/inward/record.url?scp=84871903785&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871903785&partnerID=8YFLogxK

U2 - 10.1016/j.bbmt.2012.10.028

DO - 10.1016/j.bbmt.2012.10.028

M3 - Article

C2 - 23110985

AN - SCOPUS:84871903785

SN - 1083-8791

VL - 19

SP - S102-S108

JO - Biology of Blood and Marrow Transplantation

JF - Biology of Blood and Marrow Transplantation

IS - 1 SUPPL.

ER -

Graft-versus-Host Disease: State of the Science

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this